Flarakos J - Search Results

1

LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.

Li W, Lin H, Fu Y, Flarakos J. Li W, et al. Among authors: flarakos j. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 15;1044-1045:166-176. doi: 10.1016/j.jchromb.2016.12.044. Epub 2017 Jan 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 28113139

2

Quantitative analysis of clofazimine (Lamprene®), an antileprosy agent, in human dried blood spots using liquid chromatography-tandem mass spectrometry.

Li W, Doherty J, Fu Y, Flarakos J. Li W, et al. Among authors: flarakos j. Biomed Chromatogr. 2018 Feb;32(2). doi: 10.1002/bmc.4068. Epub 2017 Sep 20. Biomed Chromatogr. 2018. PMID: 28833263

3

ICP-MS determination of serum aluminum in monkeys subcutaneously administered an alhydrogel-formulated drug candidate.

Li W, Gong J, Wang C, Lin ZJ, Flarakos J. Li W, et al. Among authors: flarakos j. Bioanalysis. 2017 Dec;9(23):1873-1881. doi: 10.4155/bio-2017-0177. Epub 2017 Nov 24. Bioanalysis. 2017. PMID: 29171771

4

Highly selective and sensitive LC-MS/MS quantification of a therapeutic protein in human serum using immunoaffinity capture enrichment.

Fu Y, Li W, Flarakos J. Fu Y, et al. Among authors: flarakos j. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Nov 15;1100-1101:83-90. doi: 10.1016/j.jchromb.2018.09.040. Epub 2018 Oct 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 30296718

5

Recommendations and best practices for calibration curves in quantitative LC-MS bioanalysis.

Fu Y, Li W, Flarakos J. Fu Y, et al. Among authors: flarakos j. Bioanalysis. 2019 Aug;11(15):1375-1377. doi: 10.4155/bio-2019-0149. Bioanalysis. 2019. PMID: 31490108 No abstract available.

6

Evaluation, identification and impact assessment of abnormal internal standard response variability in regulated LC-MS bioanalysis.

Fu Y, Barkley D, Li W, Picard F, Flarakos J. Fu Y, et al. Among authors: flarakos j. Bioanalysis. 2020 Apr;12(8):545-559. doi: 10.4155/bio-2020-0058. Epub 2020 Apr 30. Bioanalysis. 2020. PMID: 32352315 Review.

7

Critical considerations of matrix selection in LC-MS bioanalysis for toxicokinetic and pharmacokinetic assessment in drug development.

Fu Y, Li W, Flarakos J. Fu Y, et al. Among authors: flarakos j. Bioanalysis. 2021 Apr;13(8):605-608. doi: 10.4155/bio-2020-0319. Epub 2021 Mar 17. Bioanalysis. 2021. PMID: 33728968 No abstract available.

8

Differential Mobility Spectrometry Coupled with Multiple Ion Monitoring in Regulated LC-MS/MS Bioanalysis of a Therapeutic Cyclic Peptide in Human Plasma.

Fu Y, Xia YQ, Flarakos J, Tse FL, Miller JD, Jones EB, Li W. Fu Y, et al. Among authors: flarakos j. Anal Chem. 2016 Apr 5;88(7):3655-61. doi: 10.1021/acs.analchem.5b04408. Epub 2016 Mar 18. Anal Chem. 2016. PMID: 26937555

9

Practical approaches to incurred sample LC-MS/MS reanalysis: confirming unexpected results.

Li W, Lin H, Flarakos J, Tse FL. Li W, et al. Among authors: flarakos j. Anal Chem. 2013 Feb 19;85(4):2405-13. doi: 10.1021/ac3034135. Epub 2013 Jan 30. Anal Chem. 2013. PMID: 23363493

10

A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.

Li W, Luo S, Rebello S, Flarakos J, Tse FL. Li W, et al. Among authors: flarakos j. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:182-93. doi: 10.1016/j.jchromb.2014.04.012. Epub 2014 Apr 30. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 24814004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters